Clinical Characteristics of inpatients with diabetes mellitus and Sodium/glucose Cotransporter-2 Inhibitors who then develop Euglycemic Ketoacidosis
UNSWorks (University of New South Wales, Sydney, Australia) · 06.08.2025
DOI: 10.26190/unsworks/31422 ↗Kurz gefasst
Fachartikel in der Zeitschrift UNSWorks (University of New South Wales, Sydney, Australia), erschienen am 06.08.2025. Verfasst von Khan und 6 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aim
Sodium–glucose cotransporter 2 inhibitors (SGLT2i) are a novel class of oral agents with glucose lowering effect and reno- and cardio-protection increasingly used to treat type 2 diabetes mellitus (T2DM). Patients with T2DM on SGLT2i are at increased risk of diabetic ketoacidosis with normal blood glucose levels, called euglycemic ketoacidosis (eDKA). Not all patients taking SGLT2i develop this side effect; it is important to look at potential patient and other factors in those who develop eDKA to better understand this potentially severe complication.
Methods
We are conducting a cohort analysis of inpatients with T2DM admitted to a large metropolitan university teaching hospital (Liverpool, NSW). Patient factors of demographics, clinical details leading to hospital admission, other medical co-morbidities, duration and control of diabetes, and will be measured. Measured eDKA factors are: time of last SGLT2i use, when eDKA developed, voluntary or involuntary fasting, duration of fast, blood glucose & blood ketone levels, and pH, renal function, and actions to treat eDKA. Discharge information will include whether SGLT2i therapy was resumed, and follow-up plans.
Results
Between 2020-21, 15 cases of eDKA were reported and are being analysed; since January this year, 10 eDKA cases have been reported and are being analysed. Further cases will be added to the final ePoster.
Conclusions
Greater knowledge about the clinical characteristics of eDKA cases can help aid design of mitigation strategies.
Schlagwörter
Zitieren
APA
Khan, Attiya, Ramanathan, Jay, Wong, Vincent, & Lau, N. S. (2025). Clinical Characteristics of inpatients with diabetes mellitus and Sodium/glucose Cotransporter-2 Inhibitors who then develop Euglycemic Ketoacidosis. UNSWorks (University of New South Wales, Sydney, Australia). https://doi.org/10.26190/unsworks/31422
Vancouver
Khan, Attiya, Ramanathan, Jay, Wong, Vincent, et al. Clinical Characteristics of inpatients with diabetes mellitus and Sodium/glucose Cotransporter-2 Inhibitors who then develop Euglycemic Ketoacidosis. UNSWorks (University of New South Wales, Sydney, Australia). 2025. doi:10.26190/unsworks/31422
BibTeX
@article{Khan2025,
author = {Khan and Attiya and Ramanathan and Jay and Wong and Vincent and Lau, Namson S.},
title = {Clinical Characteristics of inpatients with diabetes mellitus and Sodium/glucose Cotransporter-2 Inhibitors who then develop Euglycemic Ketoacidosis},
journal = {UNSWorks (University of New South Wales, Sydney, Australia)},
year = {2025},
doi = {10.26190/unsworks/31422}
}
EUVIMED